150 related articles for article (PubMed ID: 2880862)
21. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
[TBL] [Abstract][Full Text] [Related]
22. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
[TBL] [Abstract][Full Text] [Related]
23. Nocturnal melatonin and luteinizing hormone rhythms in women with hyperprolactinemic amenorrhea.
Luboshitzky R; Lavi S; Thuma I; Lavie P
J Pineal Res; 1996 Mar; 20(2):72-8. PubMed ID: 8815190
[TBL] [Abstract][Full Text] [Related]
24. Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women.
Seki K; Mitsui C; Nagata I
Gynecol Obstet Invest; 1995; 40(1):42-5. PubMed ID: 7557642
[TBL] [Abstract][Full Text] [Related]
25. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
Scoccia B; Schneider AB; Marut EL; Scommegna A
J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
27. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic mechanisms and luteinizing hormone secretion. I. Acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyperprolactinemic women.
Evans WS; Rogol AD; MacLeod RM; Thorner MO
J Clin Endocrinol Metab; 1980 Jan; 50(1):103-7. PubMed ID: 7188612
[TBL] [Abstract][Full Text] [Related]
29. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
Perkins RB; Hall JE; Martin KA
J Clin Endocrinol Metab; 1999 Jun; 84(6):1905-11. PubMed ID: 10372685
[TBL] [Abstract][Full Text] [Related]
31. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
32. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
Melis GB; Paoletti AM; Gambacciani M; Mais V; Fioretti P
Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
[TBL] [Abstract][Full Text] [Related]
33. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
Ebling FJ; Schwartz ML; Foster DL
Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
[TBL] [Abstract][Full Text] [Related]
34. Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy.
Petraglia F; Larizza D; Maghnie M; Facchinetti F; Volpe A; Bernasconi S; Genazzani AR; Severi F
J Clin Endocrinol Metab; 1988 May; 66(5):1024-8. PubMed ID: 3129445
[TBL] [Abstract][Full Text] [Related]
35. On the role of dopamine receptors in the naloxone-induced hormonal changes in man.
Delitala G; Devilla L; Musso NR
J Clin Endocrinol Metab; 1983 Jan; 56(1):181-4. PubMed ID: 6847869
[TBL] [Abstract][Full Text] [Related]
36. Effects of naloxone on pulsatile luteinizing hormone in experimental hyperprolactinemia.
Lafuente A; Marco J; Moreno ML; Esquifino AI
Vet Hum Toxicol; 1994 Dec; 36(6):529-32. PubMed ID: 7900272
[TBL] [Abstract][Full Text] [Related]
37. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Quigley ME; Judd SJ; Gilliland GB; Yen SS
J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
[TBL] [Abstract][Full Text] [Related]
38. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
Khoury SA; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
[TBL] [Abstract][Full Text] [Related]
39. Postpartum lactational anovulation in a nonhuman primate (Macaca fascicularis): endogenous opiate mediation of suckling-induced hyperprolactinemia.
Gordon K; Hodgen GD; Richardson DW
J Clin Endocrinol Metab; 1992 Jul; 75(1):59-67. PubMed ID: 1619032
[TBL] [Abstract][Full Text] [Related]
40. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
